Since then, Ezrin expression has been linked to clinical outcome and prognosis in many cancer types including osteosarcoma, pancreatic carcinoma, hepatocellular carcinoma, and breast carcinoma[14-17]. This evidence concerns the gene EZR and osteosarcoma.